No increased risk of breast Ca, MI, or stroke in French women taking HT?

Article

At least there were no significant differences between French women taking HT and an unexposed control group for these three conditions.

At least there were no significant differences between French women taking HT and an unexposed control group for these three conditions. That was the preliminary finding from the first national prospective follow-up phase of the MISSION Study shared by Drazen S.F. Postruznik, MD, of Laboratoire Theramex, Societe de la Division Merck Serono, Monaco, at last month's North American Menopause Society's (NAMS) annual meeting. However, it was a significantly different story when it came to venous thromboembolism. Its incidence was actually greater for the women in the control group (0.57%) than in the "exposed group" (0.15%). But researchers believe that's explained by the physicians' choice of patients who were older and heavier.

Investigators set out to assess complications in randomly selected postmenopausal patients in two groups: 2,693 women taking hormone therapy commonly prescribed in France and 2,256 controls. Results showed that breast cancer incidence in the HT group was 0.64% versus 0.70% in the controls (RR exposed/control=0.914; 95% CI, 0.449-1.858). Premenopausal use of progestins didn't appear to influence breast cancer risk in either group. Incidence of postmenopausal MI and stroke didn't differ significantly in the HT group versus the controls (0.26% and 0.32%, respectively).

Related Videos
Why doxycycline PEP lacks clinical data for STI prevention in women
The importance of nipocalimab’s FTD against FNAIT | Image Credit:  linkedin.com
Enhancing cervical cancer management with dual stain | Image Credit: linkedin.com
Fertility treatment challenges for Muslim women during fasting holidays | Image Credit: rmanetwork.com
Understanding the impact of STIs on young adults | Image Credit: providers.ucsd.edu.
CDC estimates of maternal mortality found overestimated | Image Credit: rwjms.rutgers.edu.
Study unveils maternal mortality tracking trends | Image Credit: obhg.com
How Harmonia Healthcare is revolutionizing hyperemesis gravidarum care | Image Credit: hyperemesis.org
Unveiling gender disparities in medicine | Image Credit:  findcare.ahn.org.
Exploring the intersection of heart health and women's health | Image Credit: cedars-sinai.org
© 2024 MJH Life Sciences

All rights reserved.